Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges

A quantitative deficiency of normally functioning insulin-producing pancreatic beta cells is a major contributor to all common forms of diabetes. This is the underlying premise for attempts to replace beta cells in people with diabetes by pancreas transplantation, pancreatic islet transplantation, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peng, Karakose, Esra, Choleva, Lauryn, Kumar, Kunal, DeVita, Robert J., Garcia-Ocaña, Adolfo, Stewart, Andrew F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322843/
https://www.ncbi.nlm.nih.gov/pubmed/34335466
http://dx.doi.org/10.3389/fendo.2021.671946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322843/
https://www.ncbi.nlm.nih.gov/pubmed/34335466
http://dx.doi.org/10.3389/fendo.2021.671946

Ejemplares similares